Manufacture and sale of Dextropropoxyphene based products. (Darvon / Co-proxamol) was banned in India during 2013 by the Drugs Technical Advisory Board (DTAB). The UK 'Named Patient' facility relied on imports from India from 2008.
In order for the 'Named Patient' scheme to continue the NHS had to Import from Australia until production resumed in India. Production began again during 2016 following the collapse of the Indian palliative care system.
The majority of rheumatoid arthritis sufferers want is effective analgesia. This was deliberately taken away from 1.75 million UK patients by MHRA in order to increase their own income and allow the 'Giant Pharma' companies to ‘Rip Off’ the NHS with more expensive alternate analgesia!
Darvon / Co-proxamol was an extremrly effective analgesic and had been used by patients for over 50 years. Now it could be imported today for just £5.00 per pack. The maximum dose would be 8 tablets daily (212 per month) at a cost to the NHS of just £10.60 per month! (£127.20 annually)
When the ban began Co-proxamol cost just £2.70, subsequent Governments had caused the price to rise to £700.00 during November 2018 and is directly responsible for the loss of the 'Named Patient' facility which had been guaranteed by Caroline Flint Minister for Public Health, and the MHRA during 2007!
For more Information read my petition on Change UK:-